9999999997-18-005753.txt : 20180517 9999999997-18-005753.hdr.sgml : 20180517 20180516181407 ACCESSION NUMBER: 9999999997-18-005753 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180517 DATE AS OF CHANGE: 20180516 ACTION DATE: 20180517 RECEIVED DATE: 20180516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 18841240 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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